Cargando…

Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus

BACKGROUND: microRNAs (miRNAs) have been touted as potential diagnostic and prognostic biomarkers for various diseases. The aim of the present study was to evaluate the diagnostic value of miR-30a-5p and miR-182-5p for prediabetes and screen-detected type 2 diabetes mellitus (T2DM). METHODS: The stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Weale, Cecil Jack, Matshazi, Don M, Davids, Saarah F G, Raghubeer, Shanel, Erasmus, Rajiv T, Kengne, Andre Pascal, Davison, Glenda Mary, Matsha, Tandi E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762450/
https://www.ncbi.nlm.nih.gov/pubmed/33376373
http://dx.doi.org/10.2147/DMSO.S286081
_version_ 1783627808665239552
author Weale, Cecil Jack
Matshazi, Don M
Davids, Saarah F G
Raghubeer, Shanel
Erasmus, Rajiv T
Kengne, Andre Pascal
Davison, Glenda Mary
Matsha, Tandi E
author_facet Weale, Cecil Jack
Matshazi, Don M
Davids, Saarah F G
Raghubeer, Shanel
Erasmus, Rajiv T
Kengne, Andre Pascal
Davison, Glenda Mary
Matsha, Tandi E
author_sort Weale, Cecil Jack
collection PubMed
description BACKGROUND: microRNAs (miRNAs) have been touted as potential diagnostic and prognostic biomarkers for various diseases. The aim of the present study was to evaluate the diagnostic value of miR-30a-5p and miR-182-5p for prediabetes and screen-detected type 2 diabetes mellitus (T2DM). METHODS: The study included 1270 participants (207 prediabetes, 94 screen-detected diabetes and 969 normotolerant) from the Vascular and Metabolic Health (VMH) study. Whole blood levels of miR-30a-5p and miR-182-5p were quantitated by RT-qPCR. Multivariable logistic regressions were used to relate miRNAs with prediabetes or T2DM and receiver operating characteristic (ROC) curves were used to evaluate the ability of each miRNA to diagnose these conditions. RESULTS: Both miRNAs were significantly highly expressed in individuals with prediabetes or T2DM (both ≥3.2-fold, and p<0.001). We also observed significant under-expression in T2DM relative to prediabetes for miR-182-5p (0.49-fold, p=0.001). Age, sex and BMI-adjusted partial correlation coefficient analysis revealed a significant correlation between the two miRNAs across glucose tolerance statuses (r≥0.932, p<0.001). In normotolerant individuals, both miRNAs showed a negative correlation with waist circumference and positive correlation with HDL-cholesterol whilst in T2DM they correlated positively with hip circumference, 2-hour insulin, HDL- and LDL-cholesterol. Multivariable logistic regressions revealed both miRNAs to be consistently and continuously associated with prediabetes or T2DM (OR≥1.18, 95% 95% CI: 1.10–1.28, p<0.001), while only miR-182-5p associated with a reduced prevalence of T2DM relative to prediabetes (OR: 0.89, 95% CI: 0.83–0.96, p=0.003). In ROC analyses, miR-182-5p almost outperformed HbA1c in diagnosing prediabetes; area under the curve 0.74 vs 0.69. CONCLUSION: Our findings demonstrate that miR-30a-5p and miR-182-5p are associated with dysglycaemia and could potentially predict prediabetes, particularly miR-182-5p.
format Online
Article
Text
id pubmed-7762450
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77624502020-12-28 Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus Weale, Cecil Jack Matshazi, Don M Davids, Saarah F G Raghubeer, Shanel Erasmus, Rajiv T Kengne, Andre Pascal Davison, Glenda Mary Matsha, Tandi E Diabetes Metab Syndr Obes Original Research BACKGROUND: microRNAs (miRNAs) have been touted as potential diagnostic and prognostic biomarkers for various diseases. The aim of the present study was to evaluate the diagnostic value of miR-30a-5p and miR-182-5p for prediabetes and screen-detected type 2 diabetes mellitus (T2DM). METHODS: The study included 1270 participants (207 prediabetes, 94 screen-detected diabetes and 969 normotolerant) from the Vascular and Metabolic Health (VMH) study. Whole blood levels of miR-30a-5p and miR-182-5p were quantitated by RT-qPCR. Multivariable logistic regressions were used to relate miRNAs with prediabetes or T2DM and receiver operating characteristic (ROC) curves were used to evaluate the ability of each miRNA to diagnose these conditions. RESULTS: Both miRNAs were significantly highly expressed in individuals with prediabetes or T2DM (both ≥3.2-fold, and p<0.001). We also observed significant under-expression in T2DM relative to prediabetes for miR-182-5p (0.49-fold, p=0.001). Age, sex and BMI-adjusted partial correlation coefficient analysis revealed a significant correlation between the two miRNAs across glucose tolerance statuses (r≥0.932, p<0.001). In normotolerant individuals, both miRNAs showed a negative correlation with waist circumference and positive correlation with HDL-cholesterol whilst in T2DM they correlated positively with hip circumference, 2-hour insulin, HDL- and LDL-cholesterol. Multivariable logistic regressions revealed both miRNAs to be consistently and continuously associated with prediabetes or T2DM (OR≥1.18, 95% 95% CI: 1.10–1.28, p<0.001), while only miR-182-5p associated with a reduced prevalence of T2DM relative to prediabetes (OR: 0.89, 95% CI: 0.83–0.96, p=0.003). In ROC analyses, miR-182-5p almost outperformed HbA1c in diagnosing prediabetes; area under the curve 0.74 vs 0.69. CONCLUSION: Our findings demonstrate that miR-30a-5p and miR-182-5p are associated with dysglycaemia and could potentially predict prediabetes, particularly miR-182-5p. Dove 2020-12-21 /pmc/articles/PMC7762450/ /pubmed/33376373 http://dx.doi.org/10.2147/DMSO.S286081 Text en © 2020 Weale et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Weale, Cecil Jack
Matshazi, Don M
Davids, Saarah F G
Raghubeer, Shanel
Erasmus, Rajiv T
Kengne, Andre Pascal
Davison, Glenda Mary
Matsha, Tandi E
Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus
title Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus
title_full Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus
title_fullStr Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus
title_full_unstemmed Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus
title_short Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus
title_sort circulating mir-30a-5p and mir-182-5p in prediabetes and screen-detected diabetes mellitus
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762450/
https://www.ncbi.nlm.nih.gov/pubmed/33376373
http://dx.doi.org/10.2147/DMSO.S286081
work_keys_str_mv AT wealececiljack circulatingmir30a5pandmir1825pinprediabetesandscreendetecteddiabetesmellitus
AT matshazidonm circulatingmir30a5pandmir1825pinprediabetesandscreendetecteddiabetesmellitus
AT davidssaarahfg circulatingmir30a5pandmir1825pinprediabetesandscreendetecteddiabetesmellitus
AT raghubeershanel circulatingmir30a5pandmir1825pinprediabetesandscreendetecteddiabetesmellitus
AT erasmusrajivt circulatingmir30a5pandmir1825pinprediabetesandscreendetecteddiabetesmellitus
AT kengneandrepascal circulatingmir30a5pandmir1825pinprediabetesandscreendetecteddiabetesmellitus
AT davisonglendamary circulatingmir30a5pandmir1825pinprediabetesandscreendetecteddiabetesmellitus
AT matshatandie circulatingmir30a5pandmir1825pinprediabetesandscreendetecteddiabetesmellitus